hotspot -WSS

hotspot

author：Wikipedia 2025-08-12 06:44:11 - browse：9778

Adam's take main illustration — Molly Ferguson/STAT

MoonLake Immunotherapeutics, a Swiss biotech, was buried Monday under an avalanche of its own data spin.

It’s been awhile since I encountered a management team that speaks so arrogantly about the supposed supremacy of its own drug, but then fails to back up the talk with real data. MoonLake claimed its experimental antibody called sonelokimab delivered “landmark” results in a mid-stage study of psoriatic arthritis.

Landmark? That’s a strange way of describing the results of a clinical trial that showed sonelokimab topping a placebo — an easy hurdle — but failing to separate from an active treatment comparator, the generic drug adalimumab (known better as Humira).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： STAT Summit: How a Chicago ER doctor tackles gun violence

focus

knowledge

WSS

Schizophrenia gene found to be linked to cells' energy dysfunction

Senators push IRS to launch nonprofit hospital probe

Be careful with at

Beam Therapeutics to lay off 20% of its staff, re

Will Ozempic

Impact of Dobbs ruling felt at reproductive medicine meeting

hotspot

hotspot

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

Patients, digital health players weigh in on FTC's data privacy plan

Virginia high school admissions case could be legal follow

Aspartame and sugar

Jerome Adams on the need for new antivirals for Covid

Solve the antibiotic resistance crisis with preventive drugs

23andMe had bad news about my health. I wish a person had delivered it

After Optum profits sink, UnitedHealth makes changes

Drug repurposing or repositioning? The language matters

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

hotspot

Researchers explore possible ties between long Covid, menopause

Be careful with at

The EU Joint Clinical Assessment needs to live up to its promise

Medicare reduced heart disease by changing how it pays doctors

Solve the antibiotic resistance crisis with preventive drugs

Beam Therapeutics to lay off 20% of its staff, re

knowledge

focus

knowledge

focus